INTS
Intensity Therapeutics Inc. Common stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.320
Kõrge
$0.320
Madal
$0.320
Maht
2.73M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Intensity Therapeutics, Inc. Announces Pricing of Public Offering
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and...
Intensity Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and...
Intensity Therapeutics, Inc. Announces Patients Receiving INT230-6 Prior to the Start of Standard-of-Care May Achieve High Levels of Tumor Necrosis in the Ongoing Randomized Controlled Phase 2 INVINCIBLE-4 Study
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and...
Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...
Seotud aktsiad
BMEZ
BlackRock Health Sciences Term Trust Common Shares of Beneficial Interest
UI
Ubiquiti Inc.
ASIX
AdvanSix Inc.
FGBI
First Guaranty Bancshares Inc.
SUP
Superior Industries International Inc. (DE)
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.